HeartSciences (HSCS) FCF Margin (2021 - 2025)

HeartSciences' (HSCS) quarterly FCF Margin came in at 96497.15% in Q4 2025, up 6.14% on a QoQ basis from 102808.79% in Q3 2025.

HeartSciences (HSCS) FCF Margin (2021 - 2025) Analysis & Trends

HeartSciences (HSCS) has 5 years of FCF Margin data on file, last reported at 96497.15% in Q4 2025.

Quarterly FCF Margin changed N/A year-over-year to 96497.15% in Q4 2025, while the trailing twelve-month figure through Apr 2026 was 68798.95% (down 2988560.0% YoY) and the FY2026 annual result came in at 172036.61%, down 155038.0% from the prior year.
FCF Margin improved to 96497.15% in Q4 2025, from 102808.79% in the prior quarter.
In the past five years, FCF Margin ranged from a high of 9587.0% in Q3 2021 to a low of 102808.79% in Q3 2025.
A 5-year average of 45853.2% and a median of 35916.03% in 2025 frame the typical range for FCF Margin.
Annual changes were most pronounced in 2022 — FCF Margin sank 4725534 bps — and 2024, when it surged 3813463 bps.
Tracing HSCS's FCF Margin over 5 years: stood at 9587.0% in 2021, then sank by 493 bps to 56842.34% in 2022, then surged by 55 bps to 25388.18% in 2023, then surged by 43 bps to 14352.14% in 2024, then slumped by 572 bps to 96497.15% in 2025.
The last three FCF Margin figures came in at 96497.15% (Q4 2025), 102808.79% (Q3 2025), and 36566.44% (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	199.12 Bn	193.52 Bn	7.27 Bn	15.81%
2	Stryker	128.79 Bn	125.32 Bn	4.50 Bn	16.07%
3	Medtronic	119.30 Bn	110.08 Bn	6.41 Bn	21.26%
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn	23.50%
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn	33.60%
6	Dexcom	34.62 Bn	32.67 Bn	830.00 Mn	14.10%
7	GE HealthCare Technologies	34.05 Bn	31.94 Bn	2.18 Bn	1.28%
8	Koninklijke Philips	26.42 Bn	23.10 Bn	4.55 Bn	5.32%
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	18.73%
10	HeartSciences	6.38 Mn	4.68 Mn	-	-

Download Data